Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.
about
Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver diseaseChronic hepatitis C virus infection and neurological and psychiatric disorders: an overviewOutcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.Validation of the Fatigue Severity Scale in chronic hepatitis C.Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection.Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature reviewFatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).Hepatitis C treatment & management.Patient adherence issues in the treatment of hepatitis C.Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?Integrative Review of Co-Occurring Symptoms Across Etiologies of Chronic Liver Disease and Implications for Symptom Management Research and Practice.Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis.Disparities in hepatitis C testing in U.S. veterans born 1945-1965.The impact of hepatitis C virus outside the liver: Evidence from Asia.Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C.Efficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection.Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States.Hepatitis C, stigma and cure.Value anti-hepatitis C virus therapy by its clinical efficacy.
P2860
Q26752433-1ACD7791-AEBA-4E1E-911D-AE1F8C601470Q28082212-223FEA19-8884-46D7-AE81-EB0B159F0710Q30376341-D82F28B0-ED0A-4275-9D86-84031874EB2FQ31024615-FE7C1ECA-A9AD-44CD-A534-3FE32703EB23Q33890671-F7ECD9D4-3EC2-471B-B649-9F32B74F939AQ34174207-31BE089E-CEF7-4002-B639-059E00801904Q36203547-6F105442-E91D-43FA-8ABA-F91F0A76020CQ36638638-3519DEAD-C39B-4201-A01E-1A32106F1DC5Q36685609-00260206-D6BB-4F2C-ACFC-086B9EEA2EB6Q37640733-1134DAD9-821E-4D6E-97A1-885EA1762A61Q38219639-34108151-FA10-4767-AF7D-3171C8F3D6E6Q38231064-6B63D1CF-3097-44CE-B727-D875AEE02859Q38314738-67D7C5AB-A390-4BA6-BF62-3D0D70CA2753Q38528645-815AABE9-1BC2-410D-81B0-8902C77C64AAQ38846376-513E6044-A6F0-4CD8-8181-EBD6020D99E2Q38873592-8A45D63D-6D3D-4ECA-808E-570C43220658Q38982462-5A03EB25-F20B-4226-B6EA-7D32A507B52AQ39381313-7A5E1682-7C94-426E-AC03-B3AD202E7BABQ40088333-6AE3DB2C-B869-41D1-9394-1E70AC45881EQ41056478-129E2DC6-77EE-4F6F-AE87-88E4C99EFA56Q41366537-72D7F7C8-E7B8-4086-A3E2-80C3DD7AACD7Q42928878-DBEEFED5-1533-4D12-8CBA-A8D798EEBA1BQ45342412-BBB35723-3D92-4657-916C-B441ED7FD2E9
P2860
Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Fatigue before, during and aft ...... ults from the Virahep-C study.
@ast
Fatigue before, during and aft ...... ults from the Virahep-C study.
@en
type
label
Fatigue before, during and aft ...... ults from the Virahep-C study.
@ast
Fatigue before, during and aft ...... ults from the Virahep-C study.
@en
prefLabel
Fatigue before, during and aft ...... ults from the Virahep-C study.
@ast
Fatigue before, during and aft ...... ults from the Virahep-C study.
@en
P2093
P2860
P1476
Fatigue before, during and aft ...... sults from the Virahep-C study
@en
P2093
Donna M Evon
Jay H Hoofnagle
Zhen Jiang
P2860
P304
P356
10.1016/J.JHEP.2012.06.030
P577
2012-07-01T00:00:00Z